Nurse Practitioner, Family · New York, NY
NPI
1932483542
Since 2011
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
520 E 70th St, Starr 341
New York, NY, 10021
Phone (646) 962-2072
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,116
17 services
Medicare patients, 2024
14
Average age 77
Drug cost, 2024
$4.6M
1,189 prescriptions
Company payments, 2025
$422
From 9 companies
Medicare prescription drug claims, 2024
In 2024, the drug Tessa A Chamberlain prescribed most often to Medicare patients was Abiraterone Acetate, with 256 prescriptions and refills. In total Tessa A Chamberlain wrote 1,189 Medicare prescriptions that cost $4.6M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-09-16.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Abiraterone Acetate Generic | 256 | 261 | 55 | $505K |
| Prednisone Generic | 242 | 289 | 70 | $1,043 |
| Xtandi Enzalutamide | 112 | 112 | 28 | $1.4M |
| Orgovyx Relugolix | 95 | 96 | 23 | $248K |
| Nubeqa Darolutamide | 68 | 70 | 15 | $904K |
| Gabapentin Generic | 44 | 52 | 12 | $522 |
| Eliquis Apixaban | 28 | 34 | Under 11 | $20K |
| Erleada Apalutamide | 25 | 26 | Under 11 | $350K |
| Ondansetron Hcl Generic | 25 | 25 | 17 | $214 |
| Ondansetron Odt Ondansetron | 24 | 24 | 13 | $312 |
| Fotivda Tivozanib Hcl | 15 | 15 | Under 11 | $407K |
| Zytiga Abiraterone Acetate | 15 | 15 | Under 11 | $156K |
| Tamsulosin Hcl Generic | 14 | 20 | Under 11 | $141 |
| Triamcinolone Acetonide Generic | 13 | 19 | Under 11 | $182 |
| Oxybutynin Chloride Generic | 13 | 15 | Under 11 | $175 |
Brand drugs: 421 claims; generic drugs: 768 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tessa A Chamberlain $422 ($422 in general payments such as food, travel and fees) from 9 companies. The largest payer was Janssen Biotech, Inc. with $99.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 1 | $99 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $68.9 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $54.64 |
| pharmaand GmbH | 2 | $45.24 |
| Tolmar, Inc. | 2 | $45.24 |
| Genzyme Corporation SNY | 2 | $41.47 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $24.05 |
| Pfizer Inc. PFE | 1 | $22.26 |
| Merck Sharp & Dohme LLC MRK | 1 | $21.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.